Market opportunities for cancer treatments are at an all-time high but the publication rate of clinical trials is disturbingly low. Factors such as flawed study design and failure to meet endpoints have consistently hindered the drug development processes and need to be considered in more depth. SMi's Clinical Trials in Cancer conference will feature presentations from industry professionals and academic experts on managing clinical development in this crucial therapeutic area.

Now in its 9th year, Clinical Trials in Cancer has become an essential event for all those working in oncology in the pharmaceutical sector. Attend to discover the latest thinking in adaptive trial designs, gain insight into cancer biomarkers, understand the challenges of translational medicine and hear case studies on the logistical and operational issues of conducting clinical trials in Europe.

Why should you attend this event?

Hear about the latest targeted cancer therapies in personalised medicine Identify factors affecting attrition rates of oncology compounds in clinical trials Understand regulatory requirements for adaptive designs Learn about epidermal growth factor receptor inhibitors in cancer treatments Explore the potential use of novel transcriptomic-based biomarkers

Hear keynote addresses from:

• Mike Lau, Principal Clinical Development Scientist, Oncology, GlaxoSmithKline
• Panteli Theocharous, Senior Clinical Project Scientist, Ortho Biotech Oncology Research & Development
• Ridwaan Jhetam, Clinical Operations Head for Oncology and Senior Director, Johnson & Johnson

Our expert speaker line-up also includes:

Giacomo Mordenti, Senior Expert Biostatician Team Leader, Merck Serono Francesca Duchesne, Manager, INDOX Cancer Research Network, University of Oxford Iman El-Hariry, Global Head of Oncology, Astellas Pharma Europe  Ian Walker, Licensing Manager, Clinical Partnerships, Cancer Research Technology Rick Kaplan, Associate Director, National Cancer Research Network Jeff Evans, Professor of Translational Cancer Research, University of Glasgow Julian Matthews, Senior Lecturer, School of Cancer and Enabling Sciences, University of Manchester Daniel Hochhauser, Professor of Medical Oncology, UCL Cancer Institute Steen Knudsen, Chief Scientific Officer, Medical Prognosis Institute

Who should attend?

This annual event has been attended in previous years by representatives of the folowing organisations:

Venue details

Crowne Plaza St James London 45-51 Buckingham Gate London SW1E 6AF Tel: +44 (0) 207 834 6655 Fax: +44 (0) 207 6307 www.london.crowneplaza.com

Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs.  In the heart of Westminster, it is just a stones throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station.

The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu.  A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.
 
Nearest train stations:
• Victoria Station, 7 minutes’ walk
• Waterloo Station, 10 minutes by car

Underground stations:
• St James’s Park, 5 minutes’ walk (District and Circle lines)
• Victoria Station, 7 minutes' walk (Victoria, District and Circle lines)

SMi discounted rates include Continental Breakfast & VAT
£ 205.63 / Standard room / night for single occupancy
£ 229.13 Executive  room / night for single occupancy

Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.

Conference Documentation

Transcription CD ROM